Fol. Biol. 2002, 48, 242-245
https://doi.org/10.14712/fb2002048060242
Freezing and Thawing of Murine Bone Marrow-Derived Dendritic Cells Does Not Alter Their Immunophenotype and Antigen Presentation Characteristics
References
1. , J. (1999) Dendritic cell-based cancer vaccines (Editorial). Folia Biol. (Praha) 45, 71-74.
2. , J., Den Otter, W., Huland, E. (2000) Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines. Cancer Immunol. Immunother. 49, 116-122.
3. Bubeník, J., Mikyšková, R., Vonka, V., Mendoza, L., Šímová, J., Šmahel, M., Indrová, M. (2002) Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16. Vaccines (in press).
4. , M., Bubeník, J., Šímová, J., Vonka, V., Němečková, Š., Mendoza, L., Reiniš, M. (2001) Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide. Int. J. Mol. Med. 7, 97-100.
5. , H., Melchers, F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, 3, 4 or 5 using modified cDNA expression vectors. Eur. J. Immunol. 18, 97-104.
<https://doi.org/10.1002/eji.1830180115>
6. , L., Indrová, M., Hájková, R., Reiniš, M., Šmahel, M., Vonka, V., Bubeník, J., Jandlová, T. (2000) Peritumoral administration of antigen-unstimulated bone marrowderived dendritic cells inhibits tumour growth. Folia Biol. (Praha) 46, 91-97.
7. , L., Bubeník, J., Šímová, J., Korb, J., Bieblová, J., Vonka, V., Indrová, M., Mikyšková, R., Jandlová, T. (2002) Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-associated neoplasms. Folia Biol. (Praha) 48, 114-119.
8. , J., Reiniš, M., Sobota, V., Čapková, J., Bubeník, J., Jandlová, T. (2000) Irradiation of geneticaly modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, Il-2 production and higher therapeutic efficacy of the vaccines. Folia Biol. (Praha) 46, 11-16.
9. , M., Sobotková, E., Bubeník, J., Žák, R., Ludvíková, V., Hájková, R., Kovařík, J., Jelínek, F., Povýšil, C., Marinov, J., Vonka, V. (2001) Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br. J. Cancer 84, 374-380.
<https://doi.org/10.1054/bjoc.2000.1615>
